|
LRRC37B2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.969300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.601800E-02 |
| Normal-vs-Stage2 |
1.254380E-02 |
| Normal-vs-Stage3 |
3.63070000000132E-05 |
| Normal-vs-Stage4 |
4.32320000000042E-05 |
| Stage1-vs-Stage2 |
3.086800E-01 |
| Stage1-vs-Stage3 |
3.082100E-03 |
| Stage1-vs-Stage4 |
8.718600E-03 |
| Stage2-vs-Stage3 |
2.682600E-01 |
| Stage2-vs-Stage4 |
1.947970E-01 |
| Stage3-vs-Stage4 |
6.904200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.421220E-03 |
| Normal-vs-AfricanAmerican |
7.217000E-01 |
| Normal-vs-Asian |
1.909970E-02 |
| Caucasian-vs-AfricanAmerican |
8.552500E-02 |
| Caucasian-vs-Asian |
6.901400E-01 |
| AfricanAmerican-vs-Asian |
2.833600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.119730E-02 |
| Normal-vs-Female |
6.371500E-04 |
| Male-vs-Female |
5.263000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.487600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.978500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.055530E-03 |
| Normal-vs-Age(81-100Yrs) |
1.440070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.381900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.545700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.876570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.325000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.249200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.994600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.50789999667722E-08 |
| Classical-VS-Follicular |
1.302650E-01 |
| Classical-VS-Other |
8.146800E-01 |
| Classical-VS-Normal |
4.534200E-02 |
| Tall-VS-Follicular |
1.280340E-03 |
| Tall-VS-Other |
1.041190E-01 |
| Tall-VS-Normal |
2.54869999549712E-08 |
| Follicular-VS-Other |
5.117800E-01 |
| Follicular-VS-Normal |
4.796200E-03 |
| Other-VS-Normal |
5.620800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.379900E-03 |
| Normal-vs-N1 |
5.482000E-03 |
| N0-vs-N1 |
5.811200E-01 |
|
|
